PeakShares LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
1,217
+87
+8% +$88.9K 1.09% 30
2026
Q1
$1.04M Buy
1,130
+110
+11% +$112K 0.95% 55
2025
Q4
$1.1M Buy
+1,020
New +$975K 1.07% 26

Other funds holding LLY

PeakShares LLC's LLY Position: Q2 2026 in Review

PeakShares LLC increased its Eli Lilly (LLY) stake by 7.7% in Q2 2026, buying an estimated $88.9K and bringing the position to 1,217 shares worth $1.46M. The position accounts for 1.09% of the portfolio, ranked #30.

PeakShares LLC first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PeakShares LLC held 1,217 shares of Eli Lilly worth $1.46M as of Q2 2026.
  • PeakShares LLC bought 87 Eli Lilly shares in Q2 2026, an estimated $88.9K.
  • Eli Lilly made up 1.09% of PeakShares LLC's portfolio in Q2 2026, its #30 holding.
  • PeakShares LLC first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PeakShares LLC's 13F filing for Q2 2026, filed 11 Aug 2026.